{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T01:54:32Z","timestamp":1773885272704,"version":"3.50.1"},"reference-count":57,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013321","name":"Shenzhen Institutes of Advanced Technology","doi-asserted-by":"publisher","award":["ZDSYS20200811142401005"],"award-info":[{"award-number":["ZDSYS20200811142401005"]}],"id":[{"id":"10.13039\/501100013321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013321","name":"Shenzhen Institutes of Advanced Technology","doi-asserted-by":"publisher","award":["2023ZDZ08"],"award-info":[{"award-number":["2023ZDZ08"]}],"id":[{"id":"10.13039\/501100013321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013321","name":"Shenzhen Institutes of Advanced Technology","doi-asserted-by":"publisher","award":["2020ZDB26"],"award-info":[{"award-number":["2020ZDB26"]}],"id":[{"id":"10.13039\/501100013321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013321","name":"Shenzhen Institutes of Advanced Technology","doi-asserted-by":"publisher","award":["2021A1515011235"],"award-info":[{"award-number":["2021A1515011235"]}],"id":[{"id":"10.13039\/501100013321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017607","name":"Shenzhen Basic Research Program","doi-asserted-by":"publisher","award":["JCYJ20220818100801002"],"award-info":[{"award-number":["JCYJ20220818100801002"]}],"id":[{"id":"10.13039\/501100017607","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013289","name":"Shenzhen Institutes of Advanced Technology Innovation Program for Excellent Young Researchers","doi-asserted-by":"publisher","award":["E1G023"],"award-info":[{"award-number":["E1G023"]}],"id":[{"id":"10.13039\/501100013289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003762","name":"Institut Pasteur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Oncology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.omton.2025.201096","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T17:25:49Z","timestamp":1763659549000},"page":"201096","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Directed evolution generates an oncolytic Sindbis virus with enhanced tumor-killing capacity in osteosarcoma"],"prefix":"10.1016","volume":"33","author":[{"given":"Kangyixin","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinghan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongjun","family":"Mei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zijun","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuqiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.omton.2025.201096_bib1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41572-022-00409-y","article-title":"Osteosarcoma","volume":"8","author":"Beird","year":"2022","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.omton.2025.201096_bib2","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/s41571-021-00519-8","article-title":"Advancing therapy for osteosarcoma","volume":"18","author":"Gill","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.omton.2025.201096_bib3","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/14737140.2018.1413939","article-title":"Current and future therapeutic approaches for osteosarcoma","volume":"18","author":"Harrison","year":"2018","journal-title":"Expert Rev. Anticancer Ther."},{"key":"10.1016\/j.omton.2025.201096_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.780264","article-title":"Osteosarcoma and metastasis","volume":"11","author":"Sheng","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.omton.2025.201096_bib5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41413-023-00246-z","article-title":"Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment","volume":"11","author":"Tian","year":"2023","journal-title":"Bone Res."},{"key":"10.1016\/j.omton.2025.201096_bib6","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.3390\/v16071139","article-title":"Oncolytic Viral Therapy in Osteosarcoma","volume":"16","author":"Karadimas","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.omton.2025.201096_bib7","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41392-024-01856-7","article-title":"Exploring treatment options in cancer: tumor treatment strategies","volume":"9","author":"Liu","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.omton.2025.201096_bib8","doi-asserted-by":"crossref","first-page":"9663","DOI":"10.1007\/s11033-023-08809-3","article-title":"Cancer treatment therapies: traditional to modern approaches to combat cancers","volume":"50","author":"Kaur","year":"2023","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.omton.2025.201096_bib9","article-title":"Clinical cancer immunotherapy: Current progress and prospects","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omton.2025.201096_bib10","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41392-023-01407-6","article-title":"Oncolytic virotherapy: basic principles, recent advances and future directions","volume":"8","author":"Lin","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.omton.2025.201096_bib11","doi-asserted-by":"crossref","first-page":"5452","DOI":"10.3390\/cancers13215452","article-title":"Oncolytic viruses: newest frontier for cancer immunotherapy","volume":"13","author":"Rahman","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.omton.2025.201096_bib12","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1200\/PO.20.00395","article-title":"Evolving role of oncolytic virotherapy: challenges and prospects in clinical practice","volume":"5","author":"Moaven","year":"2021","journal-title":"JCO Precision Oncology"},{"key":"10.1016\/j.omton.2025.201096_bib13","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.1245\/s10434-018-6803-0","article-title":"Talimogene laherparepvec (TVEC) for the treatment of advanced melanoma: a single-institution experience","volume":"25","author":"Perez","year":"2018","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.omton.2025.201096_bib14","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s40259-022-00553-7","article-title":"Teserpaturev\/G47\u0394: first approval","volume":"36","author":"Frampton","year":"2022","journal-title":"BioDrugs"},{"key":"10.1016\/j.omton.2025.201096_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.752504","article-title":"A recombinant human adenovirus type 5 (H101) combined with chemotherapy for advanced gastric carcinoma: A retrospective cohort study","volume":"11","author":"Zhang","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.omton.2025.201096_bib16","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejphar.2018.08.042","article-title":"The advent of oncolytic virotherapy in oncology: The Rigvir\u00ae story","volume":"837","author":"Alberts","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.omton.2025.201096_bib17","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1158\/1535-7163.MCT-21-0565","article-title":"Local treatment of a pediatric osteosarcoma model with a 4-1BBL armed oncolytic adenovirus results in an antitumor effect and leads to immune memory","volume":"21","author":"Martinez-Velez","year":"2022","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.omton.2025.201096_bib18","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1158\/1078-0432.CCR-15-1899","article-title":"The oncolytic adenovirus VCN-01 as therapeutic approach against pediatric osteosarcoma","volume":"22","author":"Mart\u00ednez-V\u00e9lez","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omton.2025.201096_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001703","article-title":"Combination immunotherapy using G-CSF and oncolytic virotherapy reduces tumor growth in osteosarcoma","volume":"9","author":"Morales-Molina","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.omton.2025.201096_bib20","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/pbc.25464","article-title":"A phase I trial and viral clearance study of reovirus (Reolysin) in children with relapsed or refractory extra-cranial solid tumors: a Children's Oncology Group Phase I Consortium report","volume":"62","author":"Kolb","year":"2015","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.omton.2025.201096_bib21","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1002\/cncr.25741","article-title":"Systemic administration of reovirus (Reolysin) inhibits growth of human sarcoma xenografts","volume":"117","author":"Hingorani","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.omton.2025.201096_bib22","doi-asserted-by":"crossref","first-page":"11645","DOI":"10.1128\/JVI.76.22.11645-11658.2002","article-title":"Placement of the structural proteins in Sindbis virus","volume":"76","author":"Zhang","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.omton.2025.201096_bib23","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1128\/jvi.71.4.2819-2829.1997","article-title":"Sindbis virus replicons and Sindbis virus: assembly of chimeras and of particles deficient in virus RNA","volume":"71","author":"Frolov","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.omton.2025.201096_bib24","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/rmv.1876","article-title":"Sindbis virus as a human pathogen\u2014epidemiology, clinical picture and pathogenesis","volume":"26","author":"Adouchief","year":"2016","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.omton.2025.201096_bib25","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1365-2796.2004.01413.x","article-title":"Sindbis viruses and other alphaviruses as cause of human arthritic disease","volume":"256","author":"Laine","year":"2004","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.omton.2025.201096_bib26","doi-asserted-by":"crossref","first-page":"4738","DOI":"10.3390\/cancers15194738","article-title":"Oncolytic Viral Therapy for Glioma by Recombinant Sindbis Virus","volume":"15","author":"Sun","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.omton.2025.201096_bib27","doi-asserted-by":"crossref","first-page":"4992","DOI":"10.1128\/jvi.66.8.4992-5001.1992","article-title":"High-affinity laminin receptor is a receptor for Sindbis virus in mammalian cells","volume":"66","author":"Wang","year":"1992","journal-title":"J. Virol."},{"key":"10.1016\/j.omton.2025.201096_bib28","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/(SICI)1096-9896(199705)182:1<36::AID-PATH802>3.0.CO;2-W","article-title":"The spectrum of 67-kD laminin receptor expression in breast carcinoma progression","volume":"182","author":"Viacava","year":"1997","journal-title":"J. Pathol."},{"key":"10.1016\/j.omton.2025.201096_bib29","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1159\/000011895","article-title":"Prognostic significance of 67-kDa laminin receptor expression in advanced gastric cancer","volume":"55","author":"De Manzoni","year":"1998","journal-title":"Oncology"},{"key":"10.1016\/j.omton.2025.201096_bib30","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/(SICI)1096-9896(199608)179:4<376::AID-PATH591>3.0.CO;2-V","article-title":"Overexpression of the 67-kD laminin receptor correlates with tumour progression in human colorectal carcinoma","volume":"179","author":"Sanju\u00e1n","year":"1996","journal-title":"J. Pathol."},{"key":"10.1016\/j.omton.2025.201096_bib31","first-page":"1777","article-title":"Expression of the Mr 67,000 laminin receptor is an adverse prognostic indicator in human thyroid cancer: an immunohistochemical study","volume":"2","author":"Basolo","year":"1996","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omton.2025.201096_bib32","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/S0046-8177(96)90313-5","article-title":"Expression of the 67-kD laminin receptor, galectin-1, and galectin-3 in advanced human uterine adenocarcinoma","volume":"27","author":"Van Den Br\u00fble","year":"1996","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.omton.2025.201096_bib33","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/0959-8049(94)90464-2","article-title":"Differential expression of the 67-kD laminin receptor and 31-kD human laminin-binding protein in human ovarian carcinomas","volume":"30","author":"Van den Brule","year":"1994","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.omton.2025.201096_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020598","article-title":"Activation of cytotoxic and regulatory functions of NK cells by Sindbis viral vectors","volume":"6","author":"Granot","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.omton.2025.201096_bib35","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/mt.2013.215","article-title":"Sindbis viral vectors transiently deliver tumor-associated antigens to lymph nodes and elicit diversified antitumor CD8+ T-cell immunity","volume":"22","author":"Granot","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omton.2025.201096_bib36","doi-asserted-by":"crossref","first-page":"4553","DOI":"10.1158\/1078-0432.CCR-04-2610","article-title":"Oncolytic viral therapy for cervical and ovarian cancer cells by Sindbis virus AR339 strain","volume":"11","author":"Unno","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omton.2025.201096_bib37","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s00383-015-3784-y","article-title":"Oncolytic viral therapy for neuroblastoma cells with Sindbis virus AR339 strain","volume":"31","author":"Takenouchi","year":"2015","journal-title":"Pediatr. Surg. Int."},{"key":"10.1016\/j.omton.2025.201096_bib38","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/sj.bjc.6605209","article-title":"Oncolytic activity of Sindbis virus in human oral squamous carcinoma cells","volume":"101","author":"Saito","year":"2009","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.omton.2025.201096_bib39","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3892\/ijmm.2013.1395","article-title":"Recombination of replicon and helper RNAs and the emergence of propagation-competent vectors upon Sindbis virus vector production","volume":"32","author":"Hyv\u00e4rinen","year":"2013","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.omton.2025.201096_bib40","doi-asserted-by":"crossref","first-page":"e0091922","DOI":"10.1128\/jvi.00919-22","article-title":"TME\u039c45B Interacts with Sindbis Virus Nsp1 and Nsp4 and Inhibits Viral Replication","volume":"96","author":"Yan","year":"2022","journal-title":"J. Virol."},{"key":"10.1016\/j.omton.2025.201096_bib41","doi-asserted-by":"crossref","first-page":"8455","DOI":"10.1128\/JVI.78.16.8455-8467.2004","article-title":"PKR-dependent and-independent mechanisms are involved in translational shutoff during Sindbis virus infection","volume":"78","author":"Gorchakov","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.omton.2025.201096_bib42","doi-asserted-by":"crossref","first-page":"9031","DOI":"10.1128\/JVI.00850-09","article-title":"Random insertion mutagenesis of sindbis virus nonstructural protein 2 and selection of variants incapable of downregulating cellular transcription","volume":"83","author":"Frolov","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.omton.2025.201096_bib43","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1476-4598-9-37","article-title":"Sindbis viral vector induced apoptosis requires translational inhibition and signaling through Mcl-1 and Bak","volume":"9","author":"Venticinque","year":"2010","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.omton.2025.201096_bib44","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1128\/JVI.79.3.1487-1499.2005","article-title":"Sindbis virus translation is inhibited by a PKR\/RNase L-independent effector induced by alpha\/beta interferon priming of dendritic cells","volume":"79","author":"Ryman","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.omton.2025.201096_bib45","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2147\/OV.S176523","article-title":"Directed evolution as a tool for the selection of oncolytic RNA viruses with desired phenotypes","volume":"8","author":"Zainutdinov","year":"2019","journal-title":"Oncolytic Virother."},{"key":"10.1016\/j.omton.2025.201096_bib46","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.1038\/s41467-023-39156-3","article-title":"Directed natural evolution generates a next-generation oncolytic virus with a high potency and safety profile","volume":"14","author":"Guo","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omton.2025.201096_bib47","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01643-19","article-title":"Experimental evolution generates novel oncolytic vesicular stomatitis viruses with improved replication in virus-resistant pancreatic cancer cells","volume":"94","author":"Seegers","year":"2020","journal-title":"J. Virol."},{"key":"10.1016\/j.omton.2025.201096_bib48","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01388-18","article-title":"Sindbis virus infection causes cell death by nsP2-induced transcriptional shutoff or by nsP3-dependent translational shutoff","volume":"92","author":"Akhrymuk","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.omton.2025.201096_bib49","doi-asserted-by":"crossref","first-page":"5686","DOI":"10.1128\/JVI.02739-05","article-title":"Sindbis virus nonstructural protein nsP2 is cytotoxic and inhibits cellular transcription","volume":"80","author":"Garmashova","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.omton.2025.201096_bib50","doi-asserted-by":"crossref","first-page":"5046","DOI":"10.1128\/JVI.02746-06","article-title":"Development of Sindbis viruses encoding nsP2\/GFP chimeric proteins and their application for studying nsP2 functioning","volume":"81","author":"Atasheva","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.omton.2025.201096_bib51","doi-asserted-by":"crossref","first-page":"11254","DOI":"10.1128\/JVI.76.22.11254-11264.2002","article-title":"Roles of nonstructural protein nsP2 and alpha\/beta interferons in determining the outcome of Sindbis virus infection","volume":"76","author":"Frolova","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.omton.2025.201096_bib52","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/0042-6822(92)90268-T","article-title":"Identification of the active site residues in the nsP2 proteinase of Sindbis virus","volume":"191","author":"Strauss","year":"1992","journal-title":"Virology"},{"key":"10.1016\/j.omton.2025.201096_bib53","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1128\/jvi.33.1.463-474.1980","article-title":"Establishment and maintenance of persistent infection by Sindbis virus in BHK cells","volume":"33","author":"Weiss","year":"1980","journal-title":"J. Virol."},{"key":"10.1016\/j.omton.2025.201096_bib54","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/mt.2011.245","article-title":"Oncolytic Sindbis virus targets tumors defective in the interferon response and induces significant bystander antitumor immunity in vivo","volume":"20","author":"Huang","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omton.2025.201096_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0284645","article-title":"Effect of stimulator of interferon genes (STING) signaling on radiation-induced chemokine expression in human osteosarcoma cells","volume":"18","author":"Withers","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.omton.2025.201096_bib56","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.lfs.2007.11.025","article-title":"Interferon\u03b1 enhances etoposide-induced apoptosis in human osteosarcoma U2OS cells by a p53-dependent pathway","volume":"82","author":"Yuan","year":"2008","journal-title":"Life Sci."},{"key":"10.1016\/j.omton.2025.201096_bib57","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1471-2407-12-93","article-title":"Regulation of interferon pathway in 2-methoxyestradiol-treated osteosarcoma cells","volume":"12","author":"Wimbauer","year":"2012","journal-title":"BMC Cancer"}],"container-title":["Molecular Therapy Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329925001651?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329925001651?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T20:27:54Z","timestamp":1773865674000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950329925001651"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":57,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2950329925001651"],"URL":"https:\/\/doi.org\/10.1016\/j.omton.2025.201096","relation":{},"ISSN":["2950-3299"],"issn-type":[{"value":"2950-3299","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Directed evolution generates an oncolytic Sindbis virus with enhanced tumor-killing capacity in osteosarcoma","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omton.2025.201096","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"201096"}}